Habil Akbari

Habil Akbari is an accomplished professional with extensive experience in the pharmaceutical industry. Currently serving as an EMA GMP Auditor & Consultant at the European Medicines Agency since 2023, Habil also holds the position of Deputy CEO and Senior Consultant for hazardous aseptic processes at RastaGene Biopharmaceutical Co. Habil has consulted for multiple companies in hazardous OSD processes and aseptic processing, including Dorsa Pharmaceutical Co. and Rooyan Darou Pharmaceutical Co. Previously, Habil worked as a Qualified Person at Sobhan Oncology Pharmaceutical and Zavieh Pharmaceutical Company, along with serving as Chief Production Officer at Bakhtar Bioshimi Co. and holding leadership roles at Iranian Red Crescent Society. Habil's educational background includes ongoing PhD studies in Pharmaceutical Nanotechnology at Tehran University of Medical Sciences, alongside two previous PhDs in Clinical Pharmacy and Pharmacy.